All In MedTech

Device Trial Radar · NCT03147313

Extracorporal Shock Wave Treatment to Improve Nerve Regeneration

Extracorporal Shock Wave Treatment After Microsurgical Coaptation to Improve Nerve Regeneration

Last checked: Nov 19, 2026Latest source record: Sep 5, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

60

Planned (sponsor's estimate)

Start

Apr 18, 2017

Primary completion

Apr 2023

Study completion Jun 2023

Sponsor

Lead sponsor
Ludwig Boltzmann GesellschaftAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 10, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study evaluates the impact of extracorporeal shock wave treatment after microsurgical coaptation of finger nerves. Participants will be randomized into two treatment groups with different settings and a sham group. The participants will thereafter followed-up in a prospective, double-blind study design.

Conditions

  • Peripheral Nerve Injury

Interventions

  • MTS Medical UG Orthogold 100Device

    300 or 500 pulses, frequency 3Hz, energy 1 (0,1mJ/mm2)

  • ShamDevice

    Extracorporeal shock wave treatment will be faked.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Two Point DiscriminationTime frame: 1 year
  2. Semmes Weinstein Monofilament testTime frame: 1 year
  3. Pain/DiscomfortTime frame: 1 year

1 more outcomes with a free account

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Meidling Trauma Hospital

    Vienna, Austria · Recruiting

  • Lorenz Böhler Trauma Hospital

    Vienna, Austria · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.